Androgen deprivation therapy (ADT) for men with prostate cancer might make their bones weak. Fortunately, a common medication can make them strong again — if patients can get a prescription.

Radiotherapy and other cancer treatments can offer hope to prostate cancer patients. But for some men, certain treatments may carry risks.

Prostate cancer is one of the most common cancers in men, and cholesterol may promote its growth. Even after prostate surgery, those with high blood fat levels may have a greater risk of the cancer returning, new research suggests.

Lifestyle choices like smoking can increase your risk for cancer. But your genes may also raise your risk — particularly for prostate cancer. 

Balding and prostate cancer are two different but common concerns for many men. Now, new research suggests the two may be connected.

Doctors sometimes monitor men with prostate cancer by watching for disease signs rather than giving more treatment. But this approach may not be the best one for black men.

The prevalence and costs of new health care procedures constantly change as new techniques emerge. A new study examined one new treatment for prostate cancer.

Regular cancer screenings are widely regarded as an important part of preventive medicine, particularly for people in midlife. But those same screenings might cause more harm than good in older patients facing a limited life expectancy.

The 10-year survival rate for prostate cancer is about 99 percent, reports the American Cancer Society. While the odds for surviving this disease are great, many of those men are left with unpleasant symptoms from their treatment.

A patient's choice of doctor can go a long way towards developing a personal and professional relationship. But that selection could also play a part in what kind of treatment the physician recommends.